These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 9249647

  • 1. Pain management in osteoarthritis: the role of COX-2 inhibitors.
    Lane NE.
    J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E.
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [Abstract] [Full Text] [Related]

  • 3. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
    Bensen WG.
    J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098
    [Abstract] [Full Text] [Related]

  • 4. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Oct; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

  • 5. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A.
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib, a COX-2--specific inhibitor: the clinical data.
    Fort J.
    Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):13-8. PubMed ID: 10193998
    [Abstract] [Full Text] [Related]

  • 8. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC.
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [Abstract] [Full Text] [Related]

  • 9. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F, Michaud K, Burke TA, Zhao SZ.
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib: a COX-2 inhibitor.
    Andrews SA, Wallace CK, Davis RL.
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract] [Full Text] [Related]

  • 11. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V, Hutchins B.
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract] [Full Text] [Related]

  • 12. COX-2 inhibitors.
    Brooks PM, Day RO.
    Med J Aust; 2000 Oct 16; 173(8):433-6. PubMed ID: 11090038
    [Abstract] [Full Text] [Related]

  • 13. [Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances].
    Hinz B, Brune K.
    Wien Klin Wochenschr; 1999 Feb 12; 111(3):103-12. PubMed ID: 10093892
    [Abstract] [Full Text] [Related]

  • 14. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C.
    Bull Cancer; 2004 May 12; 91 Spec No():S125-31. PubMed ID: 15239341
    [Abstract] [Full Text] [Related]

  • 15. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K.
    Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832
    [Abstract] [Full Text] [Related]

  • 16. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 16; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 17. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A.
    Rev Med Brux; 2001 Sep 16; 22(4):A377-80. PubMed ID: 11680204
    [Abstract] [Full Text] [Related]

  • 18. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug 16; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 19. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G, Cravero E.
    Clin Ter; 2003 Aug 16; 154(1):39-43. PubMed ID: 12854282
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Aug 16; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.